Retatrutide reconstitution calculator
About retatrutide
Retatrutide (Eli Lilly’s LY3437943) is an investigational triple agonist that activates the GLP-1, GIP and glucagon receptors. In Phase 2 trials it produced some of the largest weight reductions yet reported for this drug class. As of 2026 it remains in Phase 3 testing and is not approved by the FDA, so it cannot be legally prescribed or sold as a finished medicine in the United States.
Dose ladder studied in trials (reference only)
This ladder is shown for education only. It is not a prescription, a recommendation, or a substitute for a clinician.
Important: retatrutide is not FDA-approved
Retatrutide is still in Phase 3 trials and cannot be legally prescribed or sold as a finished drug in the U.S. If you want a clinician-supervised, FDA-approved GLP-1 for weight loss today, a licensed telehealth provider can assess whether semaglutide or tirzepatide is right for you.
See FDA-approved options →Find a retatrutide trialFrequently asked questions
How do I calculate retatrutide units?
Is retatrutide FDA approved?
How much BAC water for a 10 mg retatrutide vial?
Save your protocol & get free dose reminders
We’ll email your dosing details and optional weekly reminders — so you never miss or mis-measure a dose.